Ranked API manufacturers
01 India
Makes the APIFinished dose
Credentials confirmed against the regulator files on 25 July 2026
Holds one active US DMF and 3 valid CEPs for latanoprost, filing since 2010. Its 2023 FDA inspection closed as NAI, and its GMP is recognised in 16 markets.
Last FDA inspection
2023 · NAI
GMP recognised in
16 markets
Credentials confirmed against the regulator files on 25 July 2026
Holds one active US DMF and one valid CEP for latanoprost, filing since 2013. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 26 markets.
Last FDA inspection
2025 · VAI
GMP recognised in
26 markets
03 South Korea
Makes the API
Credentials confirmed against the regulator files on 25 July 2026
Holds one active US DMF and one valid CEP for latanoprost, filing since 2007. Its 2025 FDA inspection closed as NAI.
Last FDA inspection
2025 · NAI
GMP recognised in
Not established
Credentials confirmed against the regulator files on 25 July 2026
Holds one active US DMF and one valid CEP for latanoprost, filing since 2012. Its 2019 FDA inspection closed as NAI, and its GMP is recognised in 1 market.
Last FDA inspection
2019 · NAI
GMP recognised in
1 markets
05 Italy
Makes the APIFinished dose
Credentials confirmed against the regulator files on 25 July 2026
Holds one active US DMF and one valid CEP for latanoprost, filing since 2012. Its 2022 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Last FDA inspection
2022 · VAI
GMP recognised in
1 markets
Credentials confirmed against the regulator files on 25 July 2026
Holds one active US DMF and one valid CEP for latanoprost, filing since 2018. Its 2022 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Last FDA inspection
2022 · VAI
GMP recognised in
1 markets
Credentials confirmed against the regulator files on 25 July 2026
Holds one active US DMF and one valid CEP for latanoprost, filing since 2023. Its 2023 FDA inspection closed as VAI.
Last FDA inspection
2023 · VAI
GMP recognised in
Not established
Credentials confirmed against the regulator files on 25 July 2026
Holds one active US DMF and one valid CEP for latanoprost, filing since 2020.
Last FDA inspection
Not established
GMP recognised in
Not established
Credentials confirmed against the regulator files on 25 July 2026
Holds one active US DMF and one valid CEP for latanoprost, filing since 2008.
Last FDA inspection
Not established
GMP recognised in
Not established
10 Taiwan
Makes the APIFinished dose
Credentials confirmed against the regulator files on 25 July 2026
Holds one active US DMF for latanoprost, filing since 2005. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 1 market.
Last FDA inspection
2025 · VAI
GMP recognised in
1 markets
Credentials confirmed against the regulator files on 25 July 2026
Holds one active US DMF for latanoprost, filing since 2006.
Last FDA inspection
Not established
GMP recognised in
Not established
Credentials confirmed against the regulator files on 25 July 2026
Holds one active US DMF for latanoprost, filing since 2012. Its GMP is recognised in 1 market.
Last FDA inspection
Not established
GMP recognised in
1 markets
13 Czech Republic
Makes the API
Credentials confirmed against the regulator files on 25 July 2026
Holds one active US DMF for latanoprost, filing since 2012.
Last FDA inspection
Not established
GMP recognised in
Not established
Credentials confirmed against the regulator files on 25 July 2026
Holds one valid CEP for latanoprost, filing since 2023.
Last FDA inspection
Not established
GMP recognised in
Not established
15 South Korea
Makes the APIFinished dose
Registered with SFDA (Saudi Arabia) for latanoprost. Its GMP is recognised in 3 markets.
Last FDA inspection
Not established
GMP recognised in
3 markets
How this listing is sourced Regulator filings, warehouse snapshot 9 July 2026
View profile 16 Hungary
Makes the APIFinished dose
Registered with SFDA (Saudi Arabia) for latanoprost. Its GMP is recognised in 4 markets.
Last FDA inspection
Not established
GMP recognised in
4 markets
How this listing is sourced Regulator filings, warehouse snapshot 9 July 2026
View profile 17 United States
Makes the API
Registered with PMDA (Japan) for latanoprost.
Last FDA inspection
Not established
GMP recognised in
Not established
How this listing is sourced Regulator filings, warehouse snapshot 9 July 2026
View profile 14 more manufacturers hold filings for latanoprost
The names are listed below. Ask Fred about the filings, inspection history and GMP
certificates on record for each manufacturer.
Chat with Fred, your AI analyst Contract manufacturers (4)
Contract manufacturers make to order rather than holding their own filing for this
molecule.
Finished-dose makers (84)
How this list is built
The order is set by active filings weighted by regulator, inspection outcomes and their
recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags.
Every factor appears on the card it produced.
Read the full method.
- Active US DMFs
- FDA, List of Drug Master Files
- Valid CEPs
- EDQM certificate database
- Inspection outcomes
- FDA inspection classifications
- GMP certificates
- EudraGMDP and national regulators